<DOC>
	<DOCNO>NCT00899808</DOCNO>
	<brief_summary>RATIONALE : Studying sample tumor tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . PURPOSE : This research study look molecular marker genetic marker patient undergo radiation therapy cancer .</brief_summary>
	<brief_title>Molecular Markers Genetic Markers Patients Undergoing Radiation Therapy Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine local-regional control patient undergo radiation therapy cancer , function expression specific molecular/genetic marker . Secondary - Determine complication radiation therapy patient undergo radiation therapy cancer . OUTLINE : Previously collect tissue sample analyze use immunohistochemical stain molecular/genetic study method detect marker , include p53 , cyclin D1 , HER-2-neu , bcl-2/BAX , EGFR . Patient chart also review emphasis local-regional relapse .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis cancer Undergoing radiation therapy malignant disease PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>unspecified childhood solid tumor , protocol specific</keyword>
	<keyword>hematopoietic/lymphoid cancer</keyword>
</DOC>